University of California San Francisco
Give to UCSF
Breakthrough method predicts risk of invasive breast cancer
For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) – the most common form of non-invasive breast cancer – are at risk of developing more invasive tumors in later years.
MS study suggests key role of environmental factor in the disease
Scientists are reporting what they say is compelling evidence that some powerful non-heritable, environmental factor likely plays a key role in the development of multiple sclerosis.
Antibiotic-Resistant Staph Bacterium Reveals its Deadly Secrets
Insight into pneumonia deaths due to antibiotic-resistant <cite>Staphylococcus aureus</cite> infections emerges from UCSF study.
UCSF appoints Bluestone as executive vice chancellor and provost
UCSF has appointed Jeffrey A. Bluestone, PhD, a preeminent scientist and proven campus leader, as UCSF executive vice chancellor and provost.
UCSF Rocks with First LEED Silver Status for Existing Building
UCSF recently received a green-building seal of approval for Arthur and Toni Rembe Rock Hall at the UCSF Mission Bay campus.
US Launches Novel Clinical Trial to Rapidly Screen Promising Drugs for Breast Cancer Patients
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.
Blocking cancer in its path: New cellular defect discovered
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.
Breast Cancer Lab Discoveries Quickly Lead to New Clinical Trial
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.
New cancer-fighting strategy focuses on signaling molecules
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.